RE:RE:RE:RE:Expectations longrun86 wrote: I am focussed mostly on the operating performance this Quarter.
My wish list would be revenue north of $68 million and operating EBITDA greater than $15 million.
Adding to my wish list, I would like an update on the guidance as well as some insight into capital allocation timing.
Hope you are all enjoying the summer and getting in sone quality family time!
LR
Your EBITDA wish of $15M (22% margin on $68M of revenue) may be overly optimistic since we’ll now have increased spending on marketing, Exelon costs, etc. Unless they absolutely knock the sales out of the park, of course, in which case a lower EBITDA margin would do the job.
Here’s Samira (Q1/22 earnings call):
No, so as kind of Jeff mentioned also earlier, we had in Q1, kind of because of our -- because teams were locked down for, let's say, at least half of the quarter, we really didn't have commercial or medical spend in Q1 to the level that we would normally have. As we go into Q2 and Q3, where things like conferences and meetings are all happening, we expect that -- so EBITDA margin in Q1 is disproportionately higher than where we expected for the year. What we do expect is kind of in the mid-teens, which is where we ended up for the year last year.
Last year’s EBITDA margin was 15.6%.
As far as revenue, to hit the $260 million, we need at least $65 million per quarter on average, so $68 million is certainly doable... besides, it’s in the $270 million a year range.
I do share your wish for an upwards revised revenue guidance.
Hope you're enjoying the summer as well! :)